Jeffrey Soulen, MD | |
3355 Saint Johns Ln, Ste F, Ellicott City, MD 21042-2605 | |
(410) 465-2056 | |
(667) 401-6143 |
Full Name | Jeffrey Soulen |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 40 Years |
Location | 3355 Saint Johns Ln, Ellicott City, Maryland |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285617506 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | D39080 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jeffrey Soulen, MD 2833 Montclair Dr, Ellicott City, MD 21043-3423 Ph: () - | Jeffrey Soulen, MD 3355 Saint Johns Ln, Ste F, Ellicott City, MD 21042-2605 Ph: (410) 465-2056 |
News Archive
The South Florida Sun-Sentinel on Tuesday examined how across the U.S., "some insured patients are being asked by hospitals to pay larger portions of their bills upfront - and sometimes hospitals will not do the procedures until they get their copayments."
Despite majorities expressing concern about getting the novel H1N1 (or swine) flu this year, only about one in four pregnant women or new mothers plan to get the H1N1 flu shot, according to findings from a new survey conducted on behalf of HealthyWomen by Harris Interactive.
Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.
Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced the launch of the OptiDDITM Suite, a novel assay panel that assesses the most clinically significant transporter-related drug-drug interactions (DDIs), as identified by the International Transporter Consortium (ITC) in its report "Membrane Transporters in Drug Development" (Nature Reviews-Drug Discovery, March 2010).
› Verified 1 days ago
Margaret Adams, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8388 Court Ave Ste 203, Ellicott City, MD 21043 Phone: 410-313-8119 | |
Dr. Ameya Umakant Amritwar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4100 College Ave, Ellicott City, MD 21043 Phone: 443-613-9906 | |
Archana Goel Leon-guerrero, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3375 Ellicott Center Dr, Unit 2714, Ellicott City, MD 21041 Phone: 410-750-3668 Fax: 410-750-3668 | |
Sandra Onyeagoro, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4100 College Ave, Ellicott City, MD 21043 Phone: 443-364-5500 | |
Bruce T Taylor, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4100 College Ave, Ellicott City, MD 21043 Phone: 410-465-3322 Fax: 410-461-7075 | |
Dr. Clara Jeannette Palmieri, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5074 Dorsey Hall Dr, Suite 205, Ellicott City, MD 21042 Phone: 410-992-0299 | |
Yang Ao Roby, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3355 Saint Johns Ln Ste F, Ellicott City, MD 21042 Phone: 443-355-4468 Fax: 443-355-4963 |